Kenichi Ishizawa <br/><br/>
Hematopoietic Stem Cell Transplantation and Brentuximab Vedotin for Patients with Relapsed or Refractory Hodgkin Lymphoma and Systemic Anaplastic Large-Cell Lymphoma 

<br/><br/><label>Subjects--Topical Terms: </label><br/>Computer science, information & general works